CHICAGO, ILLINOIS – MAY 14: Roundup weed control products are sold at a home improvement store on May 14, 2019 in Chicago, Illinois. A jury yesterday ordered Roundup maker Monsanto to pay more than $2 billion in damages after it was discovered that the drug caused cancer in a California couple. This is the third jury to find that Roundup causes cancer since Bayer acquired Monsanto about a year ago. Bayer shares have fallen more than 40% since the acquisition. (Photo by Scott Olson/Getty Images)
Scott Olson | Getty Images News | Getty Images
German life sciences company Bayer shares rise in early trade explain The company has won a legal victory in a lawsuit claiming exposure to its popular Roundup herbicide can cause cancer.
The stock was up 11.51% as of 12:12 pm London time.
The company announced Thursday that the U.S. Court of Appeals for the Third Circuit in Philadelphia ruled in favor of plaintiff David Schaffner’s lawsuit. claim Accused Monsanto— Acquired by Bayer in 2018 — Failure to add a cancer warning to the Roundup label violated state law.
Schaffner was diagnosed with non-Hodgkin lymphoma, a cancer that affects the lymphatic system, in 2006. is the loss of the consortium, referring to the impact of his illness on them.
Schaffner, a landscaper, claims he has been exposed to Roundup both professionally and as a private homeowner.
Chief Judge Michael Chagares, writing for the three-judge panel, said the Federal Insecticide, Fungicide and Rodenticide Act requires consistency in state legal labeling requirements, thereby avoiding the need for Obligation to add cancer warning to Penn Roundup in this case.
Bayer in legal conflict over Roundup, Reuters estimates 165,000 fees The product was sued in the United States and reportedly still had about 54,000 users as of August. Settlement amounts reached $10.9 billion in 2020.
On Thursday, Bayer noted that Philadelphia’s ruling conflicted with rulings from other federal appeals courts and called on the U.S. Supreme Court to preside.
“This federal preemption decision is a cross-cutting issue in this litigation that creates a circuit divide among federal appeals courts and requires review by the U.S. Supreme Court to resolve this important issue,” Bayer said. Legal issues.
About The Author
